Cargando…

PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients With Skin of Color: Post Hoc Analyses of the US Phase III Clinical Study Data

BACKGROUND: Limited US clinical data are available on the use of aesthetic products in patients with skin of color (SOC). OBJECTIVE: To compare the efficacy and safety of prabotulinumtoxinA for the treatment of glabellar lines in patients with and without SOC. METHODS AND MATERIALS: Post hoc analyse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor, Susan C., Grimes, Pearl E., Joseph, John H., Jonker, Anneke, Avelar, Rui L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055193/ https://www.ncbi.nlm.nih.gov/pubmed/33165078 http://dx.doi.org/10.1097/DSS.0000000000002864

Ejemplares similares

PrabotulinumtoxinA for Treatment of Millennials With Moderate to Severe Glabellar Lines: Post Hoc Analyses of the Phase III Clinical Study Data
por: Ogilvie, Patricia, et al.
Publicado: (2022)

Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies
por: Beer, Kenneth R., et al.
Publicado: (2019)

PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data
por: Solish, Nowell, et al.
Publicado: (2022)

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Lorenc, Z Paul, et al.
Publicado: (2021)

Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Lorenc, Z Paul, et al.
Publicado: (2021)

A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA
por: Rupp, David C, et al.
Publicado: (2023)

Safety and Efficacy of PrabotulinumtoxinA (Nabota(®)) Injection for Cervical and Shoulder Girdle Myofascial Pain Syndrome: A Pilot Study
por: Kim, Da-ye, et al.
Publicado: (2018)

Efficacy, Safety, and Subject Satisfaction of PrabotulinumtoxinA for Moderate-to-Severe Crow’s Feet: A Phase IV, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
por: Lee, Soo-Kyung, et al.
Publicado: (2023)

Updates in the understanding and treatments of skin and hair disorders in women of color
por: Grimes, Pearl E.
Publicado: (2015)

Angiomyolipoma of the Glabellar Region
por: Kim, Hyo Joong, et al.
Publicado: (2017)

Glabellar Presentation, Its Incidence and Termination
por: Mudaliar, A. L.
Publicado: (1934)

Glabellar flap technique in oculoplastic surgery
por: Balchev, Georgi, et al.
Publicado: (2022)

Glabellar and auricular leukemia cutis in CLL
por: Steinman, Bradley, et al.
Publicado: (2022)

Central Forehead Ischemic Skin Injury following Glabellar Botulinum: A Paradigm Microshift?
por: Hynes, Stephanie D., et al.
Publicado: (2023)

Commentary: A technical revisit to the glabellar flap
por: Singh, Manpreet, et al.
Publicado: (2022)

Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines
por: Humphrey, Shannon, et al.
Publicado: (2023)

Optimizing Outcomes When Treating Glabellar Lines
por: Solish, Nowell, et al.
Publicado: (2023)

Botulinum toxin type-A in the treatment of glabellar lines
por: Winter, Leslie, et al.
Publicado: (2009)

Botulinum toxin type A for the management of glabellar rhytids
por: Tremaine, Anne Marie, et al.
Publicado: (2010)

Diagnostic accuracy of glabellar tap sign for Parkinson’s disease
por: Nuuttila, Simo, et al.
Publicado: (2021)

Abstract 85: A Randomized, Controlled, Split-Face Study Comparing The Onset Of Action Of Prabotulinumtoxin-A And Onabotulinumtoxin-A
por: Shridharani, Sachin M., et al.
Publicado: (2020)

Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines
por: Dayan, Steven, et al.
Publicado: (2022)

A Retrospective Study of Chinese-Specific Glabellar Contraction Patterns
por: Hsieh, Daniel Meng-Yen, et al.
Publicado: (2019)

The Crest Injection Technique for Glabellar Line Correction and the Paracentral Artery
por: Tansatit, Tanvaa, et al.
Publicado: (2021)

Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines
por: Yi, Kyu-Ho, et al.
Publicado: (2022)

Acute diplopia after glabellar hyaluronic acid filler injection
por: Chung, Caroline W., et al.
Publicado: (2023)

Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study
por: Kestemont, Philippe, et al.
Publicado: (2021)

Psoriatic Lesions Following Botulinum Toxin: A Injections to the Glabellar Region
por: Ceran, Candemir, et al.
Publicado: (2015)

Glabellar vertical line as a reference goal for anteroposterior maxillary position
por: Carruitero, Marcos J., et al.
Publicado: (2019)

Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection
por: Davidova, Petra, et al.
Publicado: (2022)

Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation
por: Kim, Soo-Bin, et al.
Publicado: (2021)

The Use of a Hemi Glabellar Flap for Reconstruction of Medial Canthus Defects
por: Tan, Poh Hong, et al.
Publicado: (2022)

Treatment of glabellar lines with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Carruthers, Jean, et al.
Publicado: (2023)

Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow Position
por: Bertucci, Vince, et al.
Publicado: (2022)

P02.77. Case series to evaluate the efficacy of facial acupuncture to decrease skin roughness and depth of wrinkles in the glabellar area
por: Brodsky, M, et al.
Publicado: (2012)

The efficacy of cariprazine in chronic schizophrenia – post hoc analyses of phase II/III clinical trials
por: Falkai, P., et al.
Publicado: (2022)

Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
por: Prager, Welf
Publicado: (2013)

Utility of the Glabellar Flap in the Reconstruction of Medial Canthal Tumors after Mohs Surgery
por: Diaz Cespedes, Ricardo Andres, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3kfjg9pprdniir4hbvl1d26ph0